SCHEMBL203381

SCHEMBL203381

CSc1nc2cnc3cc(Br)ccc3c2n1CCCOC(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
RXFP1 Q9HBX9 1/20 0.40
TLR8 Q9NR97 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
ATM Q13315 1/20 0.33
HSP90AA1 P07900 3/20 0.33
HSP90AB1 P08238 3/20 0.33
MAPK14 Q16539 1/20 0.33
TSHR P16473 1/20 0.31
HTT P42858 1/20 0.31
PKM P14618 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MAPT P10636 1/20 0.31
EGFR P00533 1/20 0.31
PDE3B Q13370 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL203332 0.84 ALDH1A1 (0.42) ALDH1A1RXFP1LMNAKDM4EAPOBEC3A
SCHEMBL203737 0.80 DYRK1A (0.44) MTNR1AMTNR1BLMNAEGFR
SCHEMBL204269 0.77 ALDH1A1 (0.42) ALDH1A1RXFP1LMNAKDM4ETSHR
SCHEMBL6248929 0.71 TLR7 (0.42) TLR8LMNAATM
SCHEMBL5617953 0.70 PPARG (0.38) TLR8
SCHEMBL1775918 0.70 BRD4 (0.37) ALDH1A1RXFP1TLR8TSHRHTT
SCHEMBL3871007 0.69 TLR7 (0.39) RXFP1TLR8NPSR1
SCHEMBL3863639 0.68 TLR7 (0.44) ALDH1A1TLR8LMNATSHRNPSR1
SCHEMBL2114249 0.67 BRD4 (0.48) RXFP1
SCHEMBL3169725 0.67 TLR7 (0.43) ALDH1A1TLR8TSHRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088788-B2 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 US disclosed
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS PFIZER INC. 2009-09-03 US disclosed
WO-2007106852-A2 SUBSTITUTED FUSED[1,2]IMIDAZO[4,5-C] RING COMPOUNDS AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS IL2, IFNG, IL4 ALDH1A1 979/4885RXFP1 3248/4885TLR8 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.